Föreläsningar och seminarier OnkPat Friday Seminar: From cancer vaccines to adoptive T cell therapy: Advancing Immunotherapy strategies in solid cancer
Välkommen till OnkPat Friday Seminar med Else Marit Inderberg, PhD och forskningsledare vid Oslo University Hospital.
Läs mer om Else Marit Inderberg.
Utvalda publikationer
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM
Mol Ther 2026 Sep;():
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM
Mol Ther 2024 Jun;32(6):2021-2029
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.
Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S
Cell Rep Med 2025 Sep;6(9):102350